|
Published by: Datamonitor
Published: May. 1, 2009 - 126 Pages
Table of Contents
- CHAPTER 1 INTRODUCTION
- 1.1 What is this report about?
- 1.2 Who is the target reader?
- 1.3 How to use this report
- 1.4 Definitions
- CHAPTER 2 GLOBAL OTC PHARMACEUTICALS
- 2.1 Market Overview
- 2.2 Market Value
- 2.3 Market Segmentation I
- 2.4 Market Segmentation II
- 2.5 Market Share
- 2.6 Five Forces Analysis
- 2.7 Leading Companies
- 2.8 Distribution
- 2.9 Market Forecasts
- CHAPTER 3 OTC PHARMACEUTICALS IN ASIA-PACIFIC
- 3.1 Market Overview
- 3.2 Market Value
- 3.3 Market Segmentation I
- 3.4 Market Segmentation II
- 3.5 Market Share
- 3.6 Five Forces Analysis
- 3.7 Leading Companies
- 3.8 Distribution
- 3.9 Market Forecasts
- CHAPTER 4 OTC PHARMACEUTICALS IN EUROPE
- 4.1 Market Overview
- 4.2 Market Value
- 4.3 Market Segmentation I
- 4.4 Market Segmentation II
- 4.5 Market Share
- 4.6 Five Forces Analysis
- 4.7 Leading Companies
- 4.8 Distribution
- 4.9 Market Forecasts
- 4.10 Macroeconomic Indicators
- CHAPTER 5 OTC PHARMACEUTICALS IN AUSTRALIA
- 5.1 Market Overview
- 5.2 Market Value
- 5.3 Market Segmentation I
- 5.4 Market Segmentation II
- 5.5 Market Share
- 5.6 Five Forces Analysis
- 5.7 Leading Companies
- 5.8 Distribution
- 5.9 Market Forecasts
- 5.10 Macroeconomic Indicators
- CHAPTER 6 OTC PHARMACEUTICALS IN BELGIUM
- 6.1 Market Overview
- 6.2 Market Value
- 6.3 Market Segmentation I
- 6.4 Market Segmentation II
- 6.5 Market Share
- 6.6 Five Forces Analysis
- 6.7 Leading Companies
- 6.8 Distribution
- 6.9 Market Forecasts
- 6.10 Macroeconomic Indicators
- CHAPTER 7 OTC PHARMACEUTICALS IN BRAZIL
- 7.1 Market Overview
- 7.2 Market Value
- 7.3 Market Segmentation I
- 7.4 Market Segmentation II
- 7.5 Market Share
- 7.6 Five Forces Analysis
- 7.7 Leading Companies
- 7.8 Distribution
- 7.9 Market Forecasts
- 7.10 Macroeconomic Indicators
- CHAPTER 8 OTC PHARMACEUTICALS IN CANADA
- 8.1 Market Overview
- 8.2 Market Value
- 8.3 Market Segmentation I
- 8.4 Market Segmentation II
- 8.5 Market Share
- 8.6 Five Forces Analysis
- 8.7 Leading Companies
- 8.8 Distribution
- 8.9 Market Forecasts
- 8.10 Macroeconomic Indicators
- CHAPTER 9 OTC PHARMACEUTICALS IN CHINA
- 9.1 Market Overview
- 9.2 Market Value
- 9.3 Market Segmentation I
- 9.4 Market Segmentation II
- 9.5 Market Share
- 9.6 Five Forces Analysis
- 9.7 Leading Companies
- 9.8 Distribution
- 9.9 Market Forecasts
- 9.10 Macroeconomic Indicators
- CHAPTER 10 OTC PHARMACEUTICALS IN THE CZECH REPUBLIC
- 10.1 Market Overview
- 10.2 Market Value
- 10.3 Market Segmentation I
- 10.4 Market Segmentation II
- 10.5 Market Share
- 10.6 Five Forces Analysis
- 10.7 Leading Companies
- 10.8 Distribution
- 10.9 Market Forecasts
- 10.10 Macroeconomic Indicators
- CHAPTER 11 OTC PHARMACEUTICALS IN DENMARK
- 11.1 Market Overview
- 11.2 Market Value
- 11.3 Market Segmentation I
- 11.4 Market Segmentation II
- 11.5 Market Share
- 11.6 Five Forces Analysis
- 11.7 Leading Companies
- 11.8 Distribution
- 11.9 Market Forecasts
- 11.10 Macroeconomic Indicators
- CHAPTER 12 OTC PHARMACEUTICALS IN FRANCE
- 12.1 Market Overview
- 12.2 Market Value
- 12.3 Market Segmentation I
- 12.4 Market Segmentation II
- 12.5 Market Share
- 12.6 Five Forces Analysis
- 12.7 Leading Companies
- 12.8 Distribution
- 12.9 Market Forecasts
- 12.10 Macroeconomic Indicators
- CHAPTER 13 OTC PHARMACEUTICALS IN GERMANY
- 13.1 Market Overview
- 13.2 Market Value
- 13.3 Market Segmentation I
- 13.4 Market Segmentation II
- 13.5 Market Share
- 13.6 Five Forces Analysis
- 13.7 Leading Companies
- 13.8 Distribution
- 13.9 Market Forecasts
- 13.10 Macroeconomic Indicators
- CHAPTER 14 OTC PHARMACEUTICALS IN HUNGARY
- 14.1 Market Overview
- 14.2 Market Value
- 14.3 Market Segmentation I
- 14.4 Market Segmentation II
- 14.5 Market Share
- 14.6 Five Forces Analysis
- 14.7 Leading Companies
- 14.8 Distribution
- 14.9 Market Forecasts
- 14.10 Macroeconomic Indicators
- CHAPTER 15 OTC PHARMACEUTICALS IN INDIA
- 15.1 Market Overview
- 15.2 Market Value
- 15.3 Market Segmentation I
- 15.4 Market Segmentation II
- 15.5 Market Share
- 15.6 Five Forces Analysis
- 15.7 Leading Companies
- 15.8 Distribution
- 15.9 Market Forecasts
- 15.10 Macroeconomic Indicators
- CHAPTER 16 OTC PHARMACEUTICALS IN ITALY
- 16.1 Market Overview
- 16.2 Market Value
- 16.3 Market Segmentation I
- 16.4 Market Segmentation II
- 16.5 Market Share
- 16.6 Five Forces Analysis
- 16.7 Leading Companies
- 16.8 Distribution
- 16.9 Market Forecasts
- 16.10 Macroeconomic Indicators
- CHAPTER 17 OTC PHARMACEUTICALS IN JAPAN
- 17.1 Market Overview
- 17.2 Market Value
- 17.3 Market Segmentation I
- 17.4 Market Segmentation II
- 17.5 Market Share
- 17.6 Five Forces Analysis
- 17.7 Leading Companies
- 17.8 Distribution
- 17.9 Market Forecasts
- 17.10 Macroeconomic Indicators
- CHAPTER 18 OTC PHARMACEUTICALS IN MEXICO
- 18.1 Market Overview
- 18.2 Market Value
- 18.3 Market Segmentation I
- 18.4 Market Segmentation II
- 18.5 Market Share
- 18.6 Five Forces Analysis
- 18.7 Leading Companies
- 18.8 Distribution
- 18.9 Market Forecasts
- 18.10 Macroeconomic Indicators
- CHAPTER 19 OTC PHARMACEUTICALS IN THE NETHERLANDS
- 19.1 Market Overview
- 19.2 Market Value
- 19.3 Market Segmentation I
- 19.4 Market Segmentation II
- 19.5 Market Share
- 19.6 Five Forces Analysis
- 19.7 Leading Companies
- 19.8 Distribution
- 19.9 Market Forecasts
- 19.10 Macroeconomic Indicators
- CHAPTER 20 OTC PHARMACEUTICALS IN NORWAY
- 20.1 Market Overview
- 20.2 Market Value
- 20.3 Market Segmentation I
- 20.4 Market Segmentation II
- 20.5 Market Share
- 20.6 Five Forces Analysis
- 20.7 Leading Companies
- 20.8 Distribution
- 20.9 Market Forecasts
- 20.10 Macroeconomic Indicators
- CHAPTER 21 OTC PHARMACEUTICALS IN POLAND
- 21.1 Market Overview
- 21.2 Market Value
- 21.3 Market Segmentation I
- 21.4 Market Segmentation II
- 21.5 Market Share
- 21.6 Five Forces Analysis
- 21.7 Leading Companies
- 21.8 Distribution
- 21.9 Market Forecasts
- 21.10 Macroeconomic Indicators
- CHAPTER 22 OTC PHARMACEUTICALS IN RUSSIA
- 22.1 Market Overview
- 22.2 Market Value
- 22.3 Market Segmentation I
- 22.4 Market Segmentation II
- 22.5 Market Share
- 22.6 Five Forces Analysis
- 22.7 Leading Companies
- 22.8 Distribution
- 22.9 Market Forecasts
- 22.10 Macroeconomic Indicators
- CHAPTER 23 OTC PHARMACEUTICALS IN SINGAPORE
- 23.1 Market Overview
- 23.2 Market Value
- 23.3 Market Segmentation I
- 23.4 Market Segmentation II
- 23.5 Market Share
- 23.6 Five Forces Analysis
- 23.7 Leading Companies
- 23.8 Distribution
- 23.9 Market Forecasts
- 23.10 Macroeconomic Indicators
- CHAPTER 24 OTC PHARMACEUTICALS IN SOUTH AFRICA
- 24.1 Market Overview
- 24.2 Market Value
- 24.3 Market Segmentation
- 24.4 Market Share
- 24.5 Five Forces Analysis
- 24.6 Leading Companies
- 24.7 Distribution
- 24.8 Market Forecasts
- 24.9 Macroeconomic Indicators
- CHAPTER 25 OTC PHARMACEUTICALS IN SOUTH KOREA
- 25.1 Market Overview
- 25.2 Market Value
- 25.3 Market Segmentation I
- 25.4 Market Segmentation II
- 25.5 Market Share
- 25.6 Five Forces Analysis
- 25.7 Leading Companies
- 25.8 Distribution
- 25.9 Market Forecasts
- 25.10 Macroeconomic Indicators
- CHAPTER 26 OTC PHARMACEUTICALS IN SPAIN
- 26.1 Market Overview
- 26.2 Market Value
- 26.3 Market Segmentation I
- 26.4 Market Segmentation II
- 26.5 Market Share
- 26.6 Five Forces Analysis
- 26.7 Leading Companies
- 26.8 Distribution
- 26.9 Market Forecasts
- 26.10 Macroeconomic Indicators
- CHAPTER 27 OTC PHARMACEUTICALS IN SWEDEN
- 27.1 Market Overview
- 27.2 Market Value
- 27.3 Market Segmentation I
- 27.4 Market Segmentation II
- 27.5 Market Share
- 27.6 Five Forces Analysis
- 27.7 Leading Companies
- 27.8 Distribution
- 27.9 Market Forecasts
- 27.10 Macroeconomic Indicators
- CHAPTER 28 OTC PHARMACEUTICALS IN THE UNITED KINGDOM
- 28.1 Market Overview
- 28.2 Market Value
- 28.3 Market Segmentation I
- 28.4 Market Segmentation II
- 28.5 Market Share
- 28.6 Five Forces Analysis
- 28.7 Leading Companies
- 28.8 Distribution
- 28.9 Market Forecasts
- 28.10 Macroeconomic Indicators
- CHAPTER 29 OTC PHARMACEUTICALS IN THE UNITED STATES
- 29.1 Market Overview
- 29.2 Market Value
- 29.3 Market Segmentation I
- 29.4 Market Segmentation II
- 29.5 Market Share
- 29.6 Five Forces Analysis
- 29.7 Leading Companies
- 29.8 Distribution
- 29.9 Market Forecasts
- 29.10 Macroeconomic Indicators
- CHAPTER 30 APPENDIX
- 30.1 Data Research Methodology
AbstractDatamonitor's OTC Pharmaceuticals: Extended Global Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Scope of the Report- Contains an executive summary and data on value, volume and segmentation
- Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
- Includes a five-year forecast of the industry
Highlights
The global OTC pharmaceuticals market grew by 3.9% in 2008 to reach a value of $104.2 billion.
In 2013, the market is forecast to have a value of $124 billion, an increase of 19% since 2008.
Sales of traditional medicines account for 20.3% of the global OTC pharmaceutical market's overall value.
The Asia-Pacific accounts for 38.2% of the global OTC pharmaceutical market's value.
Pfizer generates the largest share of the global OTC pharmacetuical market's value, accounting for a 6.1%
Pharmacies and drug stores distribute 57.8% of the value in the global OTC pharmaceutical market.
Why you should buy this report- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The OTC pharmaceuticals market values the total sales of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin, other analgesics), and other OTC healthcare products including; medicated skin products (anti-bacterials, acne treatments, anti-fungals, other medicated skin products, disinfectants), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, other tape or bandage, liquid bandages), first aid kits and other OTC healthcare products (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, motion sickness).
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2009
|